Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | CDK9 | P50750 | 1/20 | 0.56 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.52 |
| ▸ | TGM2 | P21980 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MTOR | P42345 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4359332 | 0.81 | MEN1 (0.56) | SMN1; SMN2TP53EPHX1TSHREPHX2 | |
| Fenuron SCHEMBL8366971 | 0.77 | TSHR (0.64) | TSHRHSD17B10NAPRTMEN1KMT2A | |
| Fenuron SCHEMBL10806698 | 0.77 | TSHR (0.64) | TSHRHSD17B10NAPRTMEN1KMT2A | |
| Fenuron SCHEMBL62004 | 0.77 | TSHR (0.64) | TSHRHSD17B10NAPRTMEN1KMT2A | |
| Fenuron SCHEMBL9451054 | 0.77 | TSHR (0.64) | TSHRHSD17B10NAPRTMEN1KMT2A | |
| SCHEMBL9518721 | 0.77 | SMN1; SMN2 (0.56) | SMN1; SMN2TP53EPHX1TSHREPHX2 | |
| SCHEMBL6206532 | 0.77 | SMN1; SMN2 (0.56) | SMN1; SMN2TP53EPHX1TSHREPHX2 | |
| SCHEMBL9142268 | 0.77 | TGM2 (0.57) | SMN1; SMN2TP53EPHX1TSHREPHX2 | |
| SCHEMBL11229513 | 0.77 | MTOR (0.54) | SMN1; SMN2TP53EPHX1TSHREPHX2 | |
| SCHEMBL1382899 | 0.76 | MEN1 (0.67) | SMN1; SMN2TP53EPHX1TSHREPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9241544-A | — | — | None | — | — | JP | disclosed |
| WO-2012103523-A3 | NOVEL MODULATORS OF DEVELOPMENT OF ADIPOCYTE AND CANCER CELLS | RAHBAR SAMUEL (US) | 2012-09-20 | — | — | WO | disclosed |
| WO-2012103523-A2 | NOVEL MODULATORS OF DEVELOPMENT OF ADIPOCYTE AND CANCER CELLS | RAHBAR SAMUEL (US) | 2012-08-02 | — | — | WO | disclosed |
| US-20110065958-A1 | Low Temperature Curable Epoxy Compositions Containing Urea Curatives | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2011-03-17 | — | — | US | disclosed |
| CN-1295075-A | Metal organic compound and polymer therefrom | ELF ATECHOM NORTH AMERICA INC (US) | 2001-05-16 | — | — | CN | disclosed |
| EP-0991406-A4 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2000-12-13 | — | — | EP | disclosed |
| EP-0991406-A1 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-04-12 | — | — | EP | disclosed |
| WO-1998032439-A1 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-07-30 | — | — | WO | disclosed |
| JP-H09241544-A | MULTICOLOR-PATTERN COATING COMPOSITION WITH ANTIALGAL PROPERTIES | KANSAI PAINT CO LTD | 1997-09-16 | — | — | JP | disclosed |
| CN-1140176-A | Metal organic compound and polymer made therefrom | ATOCHEM NORTH AMERICA ELF (US) | 1997-01-15 | — | — | CN | disclosed |
| EP-0535184-A1 | NOVEL QUINOLONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | BOUCHARA S.A. (FR) | 1993-04-07 | — | — | EP | disclosed |
| EP-0533895-A1 | NOVEL QUINOLONES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BOUCHARA S.A. (FR) | 1993-03-31 | — | — | EP | disclosed |
| WO-1992017466-A1 | NOVEL QUINOLONES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BOUCHARA S.A. (FR) | 1992-10-15 | — | — | WO | disclosed |
| WO-1992015574-A1 | NOVEL QUINOLONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | BOUCHARA S.A. (FR) | 1992-09-17 | — | — | WO | disclosed |
| US-4740540-A | LOW-SMOKING | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1988-04-26 | — | — | US | disclosed |
| EP-0166275-A2 | Resin composition for molding material | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1986-01-02 | — | — | EP | disclosed |
| EP-0044185-A2 | Imidazolidinone derivatives | ELI LILLY AND COMPANY (US) | 1982-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065958-A1 | Low Temperature Curable Epoxy Compositions Containing Urea Curatives | H1-0, CARM1, KDM8 | SMN1; SMN2 1927/4885TP53 1722/4885EPHX1 222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.